mifepristone has been researched along with nadp in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bader, C; Monet, JD; Thomas, M | 1 |
| Benet, LZ; Jang, GR | 1 |
| He, K; Hollenberg, PF; Woolf, TF | 1 |
| Gomi, RJ; Mason, SR; Reilly, PE | 1 |
| Hermans, JJ; Maser, E; Möbus, E | 1 |
| Hollenberg, PF; Lin, HL; Zhang, H | 1 |
| Guo, C; Li, J; Li, W; Myatt, L; Sun, K; Wang, W | 1 |
7 other study(ies) available for mifepristone and nadp
| Article | Year |
|---|---|
Sex steroid hormone modulation of NADPH pathways in MCF-7 cells.
Topics: Breast Neoplasms; Cell Division; Drug Interactions; Estradiol; Glucosephosphate Dehydrogenase; Humans; Mifepristone; NADP; Norpregnadienes; Premedication; Promegestone; Tamoxifen; Tumor Cells, Cultured | 1990 |
Antiprogestin-mediated inactivation of cytochrome P450 3A4.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Estrenes; Gonanes; Hormone Antagonists; Humans; Microsomes, Liver; Midazolam; Mifepristone; Mixed Function Oxygenases; NADP; Spectrophotometry; Tissue Donors | 1998 |
Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486).
Topics: Abortifacient Agents, Steroidal; Animals; Apoenzymes; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Heme; Humans; Kinetics; Male; Mifepristone; Mixed Function Oxygenases; NADP; Rats; Rats, Inbred F344; Sodium Dodecyl Sulfate; Spectrum Analysis; Testosterone | 1999 |
Mechanism-based inhibition of rat liver microsomal diazepam C3-hydroxylase by mifepristone associated with loss of spectrally detectable cytochrome P450.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Female; Humans; Kinetics; Microsomes, Liver; Mifepristone; Mixed Function Oxygenases; NADP; Oxidoreductases, N-Demethylating; Rats; Rats, Wistar; Substrate Specificity | 1999 |
Characterization of 11beta-hydroxysteroid dehydrogenase activities in the renal cell line LLC-PK1: evidence for a third isoform?
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Animals; Cortisone; Dexamethasone; Estradiol; Glucocorticoids; Hydrocortisone; Hydroxysteroid Dehydrogenases; Kidney; Kinetics; LLC-PK1 Cells; Mifepristone; NAD; NADP; Oxidation-Reduction; Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Swine | 1999 |
Metabolic activation of mifepristone [RU486; 17beta-hydroxy-11beta-(4-dimethylaminophenyl)-17alpha-(1-propynyl)-estra-4,9-dien-3-one] by mammalian cytochromes P450 and the mechanism-based inactivation of human CYP2B6.
Topics: Animals; Apoproteins; Aryl Hydrocarbon Hydroxylases; Biotransformation; Chromatography, High Pressure Liquid; Crystallization; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme System; Dexamethasone; Electrophoresis, Polyacrylamide Gel; Enzyme Induction; Glutathione; Heme; Hormone Antagonists; Humans; In Vitro Techniques; Isoenzymes; Microsomes, Liver; Mifepristone; NADP; Oxidoreductases, N-Demethylating; Phenobarbital; Rats; Spectrometry, Mass, Electrospray Ionization; Substrate Specificity; Tandem Mass Spectrometry | 2009 |
Involvement of GR and p300 in the induction of H6PD by cortisol in human amnion fibroblasts.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Amnion; Carbohydrate Dehydrogenases; E1A-Associated p300 Protein; Extraembryonic Membranes; Fibroblasts; Glucocorticoids; Histones; Humans; Hydrocortisone; Lysine; Mifepristone; NADP; Promoter Regions, Genetic; Protein Binding; Receptors, Glucocorticoid; RNA, Small Interfering | 2012 |